Cargando…

Banking on virus-specific T cells to fulfill the need for off-the-shelf cell therapies

Adoptively transferred virus-specific T cells (VSTs) have shown remarkable safety and efficacy for the treatment of virus-associated diseases and malignancies in hematopoietic stem cell transplant (HSCT) recipients, for whom VSTs are derived from the HSCT donor. Autologous VSTs have also shown promi...

Descripción completa

Detalles Bibliográficos
Autores principales: Quach, David H., Lulla, Premal, Rooney, Cliona M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023738/
https://www.ncbi.nlm.nih.gov/pubmed/36574622
http://dx.doi.org/10.1182/blood.2022016202